Abstract
The work is devoted to the search for conditions for the sample preparation and determination of carbamazepine and oxcarbazepine and identification of the products of their metabolism and degradation in human liver (post mortem) and material evidences by gas chromatography–mass spectrometry. A QUECHERS approach was developed to the sample preparation of carbamazepine and oxcarbazepine. Amitriptyline was proposed as an internal standard. Degradation products of carbamazepine and oxcarbazepine were studied in model solutions upon alkaline and acid hydrolysis and oxidation; 14 metabolites and degradation products were identified. The main analytical characteristics of the developed procedure were determined. The limits of detection are 0.1 and 0.2 µg/g for carbamazepine and oxcarbazepine, respectively. The developed procedure complies with the Validation Guidelines of the Russian Center for Forensic Medical Examination.
Similar content being viewed by others
REFERENCES
Schmidt, D. and Elger, C.E., Epilepsy Behav., 2004, vol. 5, no. 5, p. 627.
Furst, S.M. and Uetrecht, J.P., Int. J. Immunopharmacol., 1995, vol. 17, no. 5, p. 445.
Wad, N., Guenat, C., and Krämer, G., Ther. Drug Monit., 1997, vol. 19, no. 3, p. 314.
Iida, A., Sasaki, E., Yano, A., Tsuneyama, K., Fukami, T., Nakajima, M., and Yokoi, T., Drug Metab. Dispos., 2015, vol. 43, no. 7, p. 958.
Jiang, W., Xia, T., Yun, Y., Li, M., Zhang, F., Gao, S., and Chen, W., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2019, vol. 1108, p. 17.
Eichelbaum, M., Tomson, T., Tybring, G., and Bertilsson, L., Clin. Pharmacokinet., 1985, vol. 10, no. 1, p. 80.
Knowles, S.R., Uetrecht, J., and Shear, N.H., Lancet, 2000, vol. 356, no. 9241, p. 1587.
Brenton, H., Cociglio, M., Bressolle, F., Peyriere, H., Blayac, J., and Hillairebuys, D., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2005, vol. 828, nos. 1–2, p. 80.
Csetenyi, J., Baker, K.M., Frigerio, A., and Morselli, P.L., J. Pharm. Pharmacol., 1973, vol. 25, no. 4, p. 340.
Pearce, R.E., Drug Metab. Dispos., 2002, vol. 30, no. 11, p. 1170.
Furst, S.M. and Uetrecht, J.P., Biochem. Pharmacol., 1993, vol. 45, no. 6, p. 1267.
Larkin, J., McKee, P., Forrest, G., Beastall, G., Park, B., Lowrie, J., and Brodie, M., Br. J. Clin. Pharmacol., 1991, vol. 31, no. 1, p. 65.
Flesch, G., Clin. Drug Invest., 2004, vol. 24, no. 4, p. 185.
Schütz, H., Feldmann, K.F., Faigle, J.W., Kriemler, H.P., and Winkler, T., Xenobiotica, 1986, vol. 16, no. 8, p. 769.
Mandrioli, R., Albani, F., Casamenti, G., Sabbioni, C., and Raggi, M.A., J. Chromatogr. B: Biomed. Sci. Ap-pl., 2001, vol. 762, no. 2, p. 109.
Deeb, S., McKeown, D.A., Torrance, H.J., Wylie, F.M., Logan, B.K., and Scott, K.S., J. Anal. Toxicol., 2014, vol. 38, no. 8, p. 485.
Jiang, W., Xia, T., Yun, Y., Li, M., Zhang, F., Gao, S., and Chen, W., J. Chromatogr. B: Anal. Technol. Biomed. Life Sci., 2019, vol. 1108, p. 17.
Ferrari, E., Jr. and Caldas, E.D., Forensic Sci. Int., 2018, vol. 290, p. 318.
Moffat, A.C., Osselton, M.D., Widdop, B., and Watts, J., Clarke’s Analysis of Drugs and Poisons in Pharmaceuticals, Body Fluids and Postmortem Material, London: Pharm. Press, 2011, 4th ed.
Levine, B., Phipps, R.J., Naso, C., Fahie, K., and Fowler, D., J. Anal. Toxicol., 2010, vol. 34, no. 8, p. 506.
Lionetto, L., Casolla, B., Cavallari, M., Tisei, P., Buttinelli, C., and Simmaco, M., Ther. Drug Monit., 2012, vol. 34, no. 1, p. 53.
Wu, S., Xu, W., Subhani, Q., Yang, B., Chen, D., Zhu, Y., and Li, L., Talanta, 2012, vol. 101, p. 541.
Veiga, A., Dordio, A., Carvalho, A.J.P., Teixeira, D.M., and Teixeira, J.G., Anal. Chim. Acta, 2010, vol. 674, no. 2, p. 182.
Gibbons, S.E., Wang, C., and Ma, Y., Talanta, 2011, vol. 84, no. 4, p. 1163.
Cámara, M.S., Mastandrea, C., and Goicoechea, H.C., J. Biochem. Biophys. Methods, 2005, vol. 64, no. 3, p. 153.
Kalanur, S.S. and Seetharamappa, J., Anal. Lett., 2010, vol. 43, no. 4, p. 618.
Burke, J.T. and Thénot, J.P., J. Chromatogr. B: Biomed. Sci. Appl., 1985, vol. 340, p. 199.
Godolphin, W. and Thoma, J., Clin. Chem., 1978, vol. 24, no. 3, p. 483.
Kupferberg, H.J., J. Pharm. Sci., 1972, vol. 61, no. 2, p. 284.
Least, C.J., Johnson, G.F., and Solomon, H.M., Clin. Chem., 1975, vol. 21, no. 11, p. 1658.
Abraham, C.V. and Joslin, H.D., Clin. Chem., 1976, vol. 22, no. 6, p. 769.
Trager, W.E., Levy, R.H., Patel, I.H., and Neal, J.M., J. Pharmacol. Exp. Ther., 1978, vol. 206, no. 3, p. 607.
Hallbach, J., Vogel, H., and Guder, W.G., Eur. J. Clin. Chem. Clin. Biochem., 1997, vol. 35, no. 10, p. 755.
Speed, D.J., Dickson, S.J., Cairns, E.R., and Kim, N.D., J. Anal. Toxicol., 2000, vol. 24, no. 8, p. 685.
Inotsume, N., Higashi, A., Kinoshita, E., Matsuoka, T., and Nakano, M., J. Chromatogr. B: Biomed. Sci. Appl., 1986, vol. 383, no. 1, p. 166.
Maurer, H.H., Arch. Toxicol., 1990, vol. 64, no. 7, p. 554.
Palmér, L., Bertilsson, L., Coliste, P., and Rawlins, M., Clin. Pharmacol. Ther., 1973, vol. 14, no. 5, p. 827.
Ferrari, E., Jr. and Caldas, E.D., Forensic Sci. Int., 2018, vol. 290, p. 318.
Lewis, R.J., Angier, M.K., and Johnson, R.D., J. Anal. Toxicol., 2014, vol. 38, no. 8, p. 519.
von Unruh, G.E. and Paar, W.D., Biomed. Environ. Mass Spectrom., 1986, vol. 13, no. 12, p. 651.
Erarpat, S., Bodur, S., Fırat Ayyıldız, M., Tahir Günkara, Ö., Erulaş, F., Chorme, D.S., and Bakırdere, S., Biomed. Chromatogr., 2020, vol. 34, no. 10.
Rani, S. and Malik, A.K., J. Sep. Sci., 2012, vol. 35, no. 21, p. 2970.
Barsegyan, S.S., Salomatin, E.M., Pleteneva, T.V., Maksimova, T.V., and Dolinkin, A.O., Metodicheskie rekomendatsii po validatsii analiticheskikh metodik, ispol’zuemykh v sudebno-khimicheskom i khimiko-toksikologicheskom analize biologicheskogo materiala (Guidelines on the Validation of Analytical Methods Used in Forensic Chemical and Chemical Toxicological Analysis of Biological Material), Moscow: Ross. Tsentr Sud.-Med. Ekspertizy, 2014.
ACKNOWLEDGMENTS
The study was carried out using the equipment of the Central Collective Use Center of Moscow State University “Technologies for Obtaining New Nanostructured Materials and Their Comprehensive Study”, acquired by Moscow State University under the program for updating the instrumentation base within the framework of the national project “Science” and the Development Program of Moscow State University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflicts of interest.
Additional information
Translated by O. Zhukova
Rights and permissions
About this article
Cite this article
Pirogov, A.V., Gandlevskii, N.A., Vasil’eva, A.A. et al. Highly Sensitive Determination of Carbamazepine and Oxcarbazepine and Identification of Their Degradation Products in Material Evidences and Human Cadaveric Liver by Gas Chromatography–Mass Spectrometry. J Anal Chem 78, 783–793 (2023). https://doi.org/10.1134/S1061934823060096
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1061934823060096